JAK2 p.Val617Phe (V617F) Mutation Status (Accredited)

Please note that from April 2024 this programme will be consolidated into the Myeloproliferative Neoplasms Diagnostic Testing programme (Click here) and is no longer available as a stand-alone programme.

Example JAK2 p.Val617Phe (V617F) Mutation Status Report
Annotated Trial JAK2 232401 v1.0.0 Repor[...]
Adobe Acrobat document [992.2 KB]
JAK2 p.Val617Phe (V617F) Mutation Status Performance Monitoring System
Performance Monitoring System for the JA[...]
Adobe Acrobat document [81.7 KB]
JAK2 232403 cover sheet
JAK2 232403 cover sheet.pdf
Adobe Acrobat document [96.1 KB]
Print | Sitemap

Follow Us Online
Facebook Twitter LinkedIn Youtube


Last updated 14/06/2024 © UK NEQAS for Leucocyte Immunophenotyping not to be reproduced in all or part without permission.

This website uses cookies. For more information please click here.

Please click here for our privacy policy.

The UK NEQAS Organisation is a Company Limited by Guarantee (No.3012351) and a Registered UK Charity (No.1044013).